In Case You Missed It: White House Celebrates End of X-Waiver Requirement, NACDS-Backed Law Change Included in December Omnibus Bill
A White House ceremony on Tuesday marked the end of the “X-waiver” requirement.
IN CASE YOU MISSED IT: FL Media Cite NACDS Widely on Gov. DeSantis’ PBM Reform Proposal NACDS’ engagement leverages bipartisan momentum for pro-patient, pro-pharmacy PBM reform at state and federal levels
NACDS’ engagement leverages bipartisan momentum for pro-patient, pro-pharmacy PBM reform at state and federal levels.
In Case You Missed It: NACDS Health Care Outlook 2023 in Chain Drug Review
The NACDS-authored column previews the policy outlook for the coming year — and what lies ahead for the future of the industry.
In Case You Missed It: INFORM Consumers Act Becomes Law as Part of FY 2023 Omnibus Appropriations Bill
Inclusion of the INFORM Consumers Act marks a major bipartisan step toward curbing the organized retail crime networks jeopardizing Americans’ safety.
In Case You Missed It: Media Amplify NACDS’ Call for PREP Act Clarity
CNBC quoted NACDS on its call for the Biden Administration to maintain patients’ access to pharmacies in the effort to keep COVID-19 and flu at bay.
In Case You Missed It: Key Moments from the 2022 NACDS Total Store Expo
From August 27-29, small, mid-size and large companies converged at the Boston Convention & Exhibition Center to collaborate, connect and foster strategic business partnerships.
In Case You Missed It: NACDS RxIMPACT Showers Congress with a Record-Breaking 60 Tours in 25 Days
One month ago, NACDS RxIMPACT said it would push for congressional pharmacy tours with only 25 in-district workdays left in July and August -- and it did just that.
In Case You Missed It: Boston Business Journal Welcomes NACDS Total Store Expo
With the 2022 NACDS Total Store Expo set to launch, the Boston Business Journal this morning published an op-ed authored by NACDS President & CEO Steven C. Anderson.
In Case You Missed It: Three Developments in NACDS’ Push for PBM Reform in the Media, Federal & State Arenas
Last week, NACDS took issue with an op-ed in The Wall Street Journal titled, “In Defense of Pharmacy Benefit Managers (PBMs),” which asserted that “swarms of drug-company lobbyists appear to have united both parties in opposition to [PBMs]” and that PBMs – unreasonably – “are taking the blame for high drug prices.”
In Case You Missed It: NACDS RxIMPACT Advocates Push Pharmacy’s Agenda in Summer Months
With only 25 in-district work days left in July and August, the pharmacy community continues its great work promoting pro-patient, pro-pharmacy policy priorities to Members of Congress and their staff via the NACDS RxIMPACT Pharmacy Tour Program.
